Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells.
D000818:Animals; D001386:Azides / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005947:Glucose / Q000494:pharmacology; D007700:Kinetics; D007739:L Cells / Q000378:metabolism; D007939:Leukemia L1210 / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D008727:Methotrexate / Q000378:metabolism*; D051379:Mice; D014316:Tritium; D014750:Vincristine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014867:Water
D001386:Azides; D002712:Chlorides; D014867:Water; D014316:Tritium; D014750:Vincristine; D004247:DNA; D005947:Glucose; D008727:Methotrexate